Wealth Quarterback’s GSK GSK Stock Holding History

Wealth Quarterback’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$203K	Buy	4,207 +36	+0.9%	+$1.84K	0.06%	172
2026 Q2	$219K	Sell	4,171 -308	-7%	-$16.3K	0.07%	162
2026 Q1	$247K	Buy	4,479 +33	+0.7%	+$1.79K	0.1%	144
2025 Q4	$218K	Buy	+4,446	New	+$207K	0.08%	144
2021 Q3	$23K	Buy	1,986 +1,322	+199%	+$66.4K	0.02%	343
2021 Q2	$34K	Buy	+664	New	+$31.9K	0.02%	282
2020 Q2	–	Sell	-1,627	Closed	-$74.7K	–	368
2020 Q1	$74.7K	Sell	1,627 -432	-21%	-$23K	0.07%	176
2019 Q4	$121K	Buy	+2,059	New	+$115K	0.11%	144

Other funds holding GSK

Mondrian Investment Partners London, United Kingdom $5.39B AUM 14.53% 1-Year Est. Return

BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return

Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

ABC Arbitrage Paris, France $1.02B AUM 30.46% 1-Year Est. Return

Foster Victor Wealth Advisors Greenville, South Carolina $2.02B AUM 20.94% 1-Year Est. Return

Sound Income Strategies Ft Lauderdale, Florida $2.24B AUM 8.38% 1-Year Est. Return

Euro Pacific Asset Management Dorado, Puerto Rico $1.22B AUM 22.48% 1-Year Est. Return

Keystone Financial Planning Cleveland, Ohio $404M AUM 16.77% 1-Year Est. Return

Bell Bank Fargo, North Dakota $2.66B AUM 18.07% 1-Year Est. Return

Wealth Quarterback's GSK Position: Q3 2026 in Review

Wealth Quarterback increased its GSK (GSK) stake by 0.86% in Q3 2026, buying an estimated $1.84K and bringing the position to 4,207 shares worth $203K. The position accounts for 0.06% of the portfolio, ranked #172.

Wealth Quarterback first reported a position in GSK in Q4 2019 and has held it in 8 quarters since. The position peaked at $247K in Q1 2026. 279 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

Wealth Quarterback held 4,207 shares of GSK worth $203K as of Q3 2026.
Wealth Quarterback bought 36 GSK shares in Q3 2026, an estimated $1.84K.
GSK made up 0.06% of Wealth Quarterback's portfolio in Q3 2026, its #172 holding.
Wealth Quarterback first reported a position in GSK in Q4 2019 and has held it in 8 quarters since.
Wealth Quarterback's GSK position peaked at $247K in Q1 2026.
279 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Wealth Quarterback's 13F filing for Q3 2026, filed 20 Oct 2026.